Our sole focus is managing early-phase clinical studies through to success. bioaccess® has the expertise and customized approach you need to navigate your company towards an acquisition.
Our Service Capabilities for Clinical Studies Include:
Viabilidad y selección del centro de investigación y del investigador principal (IP).
Revisión y comentarios sobre los documentos de estudio para cumplir los requisitos del país.
Trial set-up, start-up, and regulatory approval (institutional review board, ethics committee and health ministry).
Import permit and nationalization of investigational products.
Estudiar la gestión y el seguimiento de los proyectos.
Presentación de informes (estado del estudio, inventario, acontecimientos adversos graves y no graves).
Market Access Services for Latin America: Accelerate Entry into Mexico, Brazil, Colombia,Peru & Chile.
Unlock Latin America’s $11B MedTech & Biopharma Market with bioaccess®’s End-to-EndMarket Access Solutions
Why Choose bioaccess®? 15+ Years of Experience | 100+ Startups Accelerated | 40% Faster Approvals vs. US/EU We cut through Latin America’s regulatory complexity so you can focus on innovation. From COFEPRIS approvals in 6 weeks to ANVISA’s new foreign-assessment pathways, we turn fragmented processes into streamlined market entry.
Core Services:
Regulatory Strategy & Registration
Secure approvals 50% faster with localized expertise.
